Related to Fraunhofer Center Wins Up to $9.9M for Next-Gen Anthrax Vaccines

• FDA Awards Biosearch $3.4M for Surveillance Methods to Be Used in Pathogen Detection
  
• GSK Furthers Interest in China through Pediatric Vaccines JV with Initial $32M Investment
  
• Gen-Probe to Pay $60M in Prodesse Buyout
  
• Fast EU Approval of Baxter’s H1N1 Flu Vaccine Enabled by EMEA’s Mock-Up Licensure Process
  
• Helicos Receives $2.9M to Augment Single-Molecule Sequencing Technology
  
• Neumedicines Obtains $4.9M to Support Development of Preclinical Radiomitigator
  
• hESCs May Serve As a Colon Cancer Vaccine
  
• Intralytix Wins U.S. Army Contract to Develop Phage-Based Probiotic Against Shigella Infection
  
• TGen Named In Silico Center of Excellence
  
• Clemson University Obtains $9.3M for Tissue Regeneration Center
  
• Formatech to Donate Services to Formulate and Fill a GeoVax HIV Vaccine
  
• GSK Obtains FDA Nod for HPV Vaccine
  
• Gates Foundation Pledges $115M to Medicines for Malaria Venture
  
• GSK’s Seasonal Flu Vaccine Green-Lighted for Use in Children
  
• Daiichi Sankyo and MorphoSys Collaborate on Antibody Therapeutics Against Nosocomial Infections
  
• Novavax Taps Xcellerex to Bolster Flu Vaccine Production
  
• ZyGEM and Phthisis Diagnostics to Develop Tools to Detect Infectious Pathogens
  
• BD to Acquire HandyLab for Molecular Diagnostic Automation Platform
  
• Scripps-Led Consortium that Combines Physics and Oncology Receives $10M
  
• FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pathogens